Room temperature stable injectable solution for injection of Abaloparatide, comprises Abaloparatide, and stabilizer of L-methionine, disodium Ethylenediamine tetraacetic acid, D-alpha-tocopheryl polyethylene glycol succinate, hydroxypropyl betadex, mannitol, S-methyl-L- cysteine or its mixture
	KATARIYA P A; PATEL N C; PAWAR S S; RATHOD H R; NAGINBHAI P B
	2023-08-04
专利权人	PRECISE BIOPHARMA PVT LTD (PREC-Non-standard)
申请日期	2023-08-04
专利号	IN202422047990-A
成果简介	NOVELTY - Room temperature stable injectable solution comprises 0.25-5 mg/ml Abaloparatide and stabilizer selected from 0.1-10 mg/ml 5 L-methionine, 0.1-4 mg/ml disodium Ethylenediamine tetraacetic acid (EDTA), 5-100 mg/ml D-alpha-tocopheryl polyethylene glycol succinate, 50-500 mg/ml hydroxypropyl betadex, 5-100 mg/ml mannitol, 0.1-10 mg/ml S-methyl-L- cysteine or its mixture. The solution is stable for at least 6 months when stored at 25 °C temperature and 60 % relative humidity, where the total impurities of the solution are not more than 2 %. The single maximum impurity is not more than 1 % after 6 months when stored at 25 °C temperature and 60 % relative humidity. USE - Room temperature stable injectable solution for injection of Abaloparatide. ADVANTAGE - The solution is stable at room temperature which overcomes the limitations of the currently marketed formulation.
IPC 分类号	A61K-038/29 ; A61K-047/10 ; A61K-009/00 ; A61K-009/19 ; A61P-017/00
国家	印度
专业领域	医药卫生
语种	英语
成果类型	专利
文献类型	科技成果
条目标识符	http://119.78.100.226:8889/handle/3KE4DYBR/13168
专题	中国科学院新疆生态与地理研究所
作者单位	PRECISE BIOPHARMA PVT LTD (PREC-Non-standard)
推荐引用方式 GB/T 7714	KATARIYA P A,PATEL N C,PAWAR S S,et al. Room temperature stable injectable solution for injection of Abaloparatide, comprises Abaloparatide, and stabilizer of L-methionine, disodium Ethylenediamine tetraacetic acid, D-alpha-tocopheryl polyethylene glycol succinate, hydroxypropyl betadex, mannitol, S-methyl-L- cysteine or its mixture. IN202422047990-A[P]. 2023.

条目包含的文件
条目无相关文件。

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。